Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 3/20 | 0.54 |
| ▸ | MAP3K11 | Q16584 | 2/20 | 0.44 |
| ▸ | MAP3K9 | P80192 | 1/20 | 0.44 |
| ▸ | CDK5 | Q00535 | 4/20 | 0.43 |
| ▸ | DYRK1A | Q13627 | 4/20 | 0.43 |
| ▸ | CDK5R1 | Q15078 | 3/20 | 0.43 |
| ▸ | GSK3A | P49840 | 1/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | CCNE2 | O96020 | 2/20 | 0.39 |
| ▸ | CDK4 | P11802 | 2/20 | 0.39 |
| ▸ | CCND1 | P24385 | 2/20 | 0.39 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.39 |
| ▸ | CDK2 | P24941 | 2/20 | 0.39 |
| ▸ | CAMK2B | Q13554 | 2/20 | 0.39 |
| ▸ | CAMK2G | Q13555 | 2/20 | 0.39 |
| ▸ | CAMK2D | Q13557 | 2/20 | 0.39 |
| ▸ | CAMK2A | Q9UQM7 | 2/20 | 0.39 |
| ▸ | CLK1 | P49759 | 1/20 | 0.38 |
| ▸ | GABRP | O00591 | 3/20 | 0.38 |
| ▸ | GABRD | O14764 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18593650 | 0.90 | AHR (0.55) | AHRMAP3K11MAP3K9CDK5DYRK1A | |
| SCHEMBL19866497 | 0.87 | AHR (0.42) | AHRMAP3K11MAP3K9CDK5DYRK1A | |
| SCHEMBL30007687 | 0.82 | MAP3K11 (0.44) | AHRMAP3K11MAP3K9CDK5DYRK1A | |
| SCHEMBL16201582 | 0.82 | MAP3K11 (0.44) | AHRMAP3K11MAP3K9CDK5DYRK1A | |
| SCHEMBL30019295 | 0.82 | MAP3K11 (0.44) | AHRMAP3K11MAP3K9CDK5DYRK1A | |
| SCHEMBL27142939 | 0.81 | IDO1 (0.42) | AHRMAP3K11MAP3K9CDK5DYRK1A | |
| SCHEMBL24519133 | 0.80 | HPGD (0.45) | AHRMAP3K11MAP3K9CDK5DYRK1A | |
| SCHEMBL30388393 | 0.79 | CCNE2 (0.43) | AHRMAP3K11MAP3K9CDK5DYRK1A | |
| SCHEMBL25202208 | 0.79 | CCNE2 (0.43) | AHRMAP3K11MAP3K9CDK5DYRK1A | |
| SCHEMBL17465511 | 0.78 | MAP3K11 (0.51) | MAP3K11MAP3K9CDK5DYRK1ACDK5R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10230056-B2 | Heterocyclic compound and organic light emitting element comprising same | LG CHEM, LTD. (KR) | 2019-03-12 | — | — | US | disclosed |
| US-20180047914-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-02-15 | — | — | US | disclosed |
| US-20180047914-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-02-15 | — | — | US | disclosed |
| WO-2017034303-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2017-03-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10230056-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, NR2E3 | AHR 27/4885MAP3K11 3863/4885MAP3K9 3934/4885 |
| US-20180047914-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, NR2E3 | AHR 27/4885MAP3K11 3863/4885MAP3K9 3934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.